Pull 4 Parkinson’s Foundation, Inc., a registered 501(c)(3) public charity,
funds cure and care research conducted by the Parkinson's disease community.
Learn More or Donate.

409 Parkinson’s Trials Are Recruiting

Trial Name Last Updated
Immersive Virtual Reality to Improve Gait in Parkinson's Disease 03/19/2019
Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal 03/19/2019
Ambroxol as a Treatment for Parkinson's Disease Dementia 03/19/2019
Cognitive Abilities in Brain Damaged Patients 03/18/2019
Noninvasive Brain Stimulation Training 03/18/2019
Biomarkers of Synaptic Damage in Multiple Sclerosis 03/18/2019
Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease? 03/18/2019
Fecal Microbiota Transplantation As a Potential Treatment for Parkinson's Disease 03/15/2019
Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian Cancer 03/15/2019
Cost-effectiveness of Nursing Interventions for Patients With PD 03/15/2019
Molecular Pathology and Neuronal Networks in LRRK2 Parkinson's Disease 03/15/2019
A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Patients With Motor Fluctuations 03/15/2019
Clinical Laboratory Evaluation of Chronic Autonomic Failure 03/15/2019
VY-AADC02 for Parkinson's Disease With Motor Fluctuations 03/15/2019
ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease 03/15/2019
D-aspartate and Therapeutic Exercise 03/15/2019
Predictors of Motor Progression in Parkinson's Disease 03/15/2019
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort 03/15/2019
Electrophysiology of Brain Activity During Electrode Implantation in Patients Treated With Deep Brain Stimulation 03/14/2019
Idiopathic Parkinson's Progression and Dopamine Transporter SPECT 03/14/2019
Alpha-synuclein Level in Saliva to Differentiate Between Idiopathic Parkinson Disease and Iatrogenic Parkinsonian Syndrome 03/14/2019
A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of GZ/SAR402671 in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation 03/14/2019

Page 1 of 19 pages  1 2 3 >  Last ›

All ClinicalTrials.gov articles provided courtesy of National Library of Medicine (NLM).